Bending tau into shape: the emerging role of peptidyl-prolyl isomerases in tauopathies
- PMID: 21523562
- PMCID: PMC3260650
- DOI: 10.1007/s12035-011-8182-4
Bending tau into shape: the emerging role of peptidyl-prolyl isomerases in tauopathies
Abstract
The Hsp90-associated cis-trans peptidyl-prolyl isomerase--FK506 binding protein 51 (FKBP51)--was recently found to co-localize with the microtubule (MT)-associated protein tau in neurons and physically interact with tau in brain tissues from humans who died from Alzheimer's disease (AD). Tau pathologically aggregates in neurons, a process that is closely linked with cognitive deficits in AD. Tau typically functions to stabilize and bundle MTs. Cellular events like calcium influx destabilize MTs, disengaging tau. This excess tau should be degraded, but sometimes it is stabilized and forms higher-order aggregates, a pathogenic hallmark of tauopathies. FKBP51 was also found to increase in forebrain neurons with age, further supporting a novel role for FKBP51 in tau processing. This, combined with compelling evidence that the prolyl isomerase Pin1 regulates tau stability and phosphorylation dynamics, suggests an emerging role for isomerization in tau pathogenesis.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3260650/bin/nihms346544f1.gif)
Similar articles
-
The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease.J Neurochem. 2015 Apr;133(1):1-13. doi: 10.1111/jnc.13033. Epub 2015 Feb 24. J Neurochem. 2015. PMID: 25628064 Free PMC article. Review.
-
The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.J Neurosci. 2010 Jan 13;30(2):591-9. doi: 10.1523/JNEUROSCI.4815-09.2010. J Neurosci. 2010. PMID: 20071522 Free PMC article.
-
Distinct functions of cis and trans phosphorylated tau in Alzheimer's disease and their therapeutic implications.Curr Mol Med. 2013 Aug;13(7):1098-109. doi: 10.2174/1566524011313070001. Curr Mol Med. 2013. PMID: 23157676
-
Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker.Neurobiol Aging. 2013 Mar;34(3):757-69. doi: 10.1016/j.neurobiolaging.2012.08.004. Epub 2012 Aug 25. Neurobiol Aging. 2013. PMID: 22926167
-
Pin1: a new outlook in Alzheimer's disease.Curr Alzheimer Res. 2011 Sep;8(6):615-22. doi: 10.2174/156720511796717140. Curr Alzheimer Res. 2011. PMID: 21605045 Review.
Cited by
-
Differential regulation of MAP2 by phosphorylation events in proline-rich versus C-terminal domains.FASEB J. 2023 Oct;37(10):e23194. doi: 10.1096/fj.202300486R. FASEB J. 2023. PMID: 37702880
-
Chaperoning of specific tau structure by immunophilin FKBP12 regulates the neuronal resilience to extracellular stress.Sci Adv. 2023 Feb 3;9(5):eadd9789. doi: 10.1126/sciadv.add9789. Epub 2023 Feb 1. Sci Adv. 2023. PMID: 36724228 Free PMC article.
-
Tau Protein Interaction Partners and Their Roles in Alzheimer's Disease and Other Tauopathies.Int J Mol Sci. 2021 Aug 26;22(17):9207. doi: 10.3390/ijms22179207. Int J Mol Sci. 2021. PMID: 34502116 Free PMC article. Review.
-
FKBP10 Acts as a New Biomarker for Prognosis and Lymph Node Metastasis of Gastric Cancer by Bioinformatics Analysis and in Vitro Experiments.Onco Targets Ther. 2020 Jul 28;13:7399-7409. doi: 10.2147/OTT.S253154. eCollection 2020. Onco Targets Ther. 2020. PMID: 32801763 Free PMC article.
-
Post-translational modifications and stress adaptation: the paradigm of FKBP51.Biochem Soc Trans. 2020 Apr 29;48(2):441-449. doi: 10.1042/BST20190332. Biochem Soc Trans. 2020. PMID: 32318709 Free PMC article. Review.
References
-
- Oddo S, et al. Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39(3):409–21. - PubMed
-
- Mukaetova-Ladinska EB, et al. Alpha-synuclein inclusions in Alzheimer and Lewy body diseases. J Neuropathol Exp Neurol. 2000;59(5):408–17. - PubMed
-
- Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–59. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous